The Peterson laboratory conducts research at the interface between chemistry and biology. They specialize in molecular design, organic synthesis, medicinal chemistry, and chemical biology. They investigate anticancer agents, antiviral agents, molecular probes, fluorophores, and new approaches for the delivery of drugs and biological therapeutics.
Blake Peterson is a Distinguished Professor in the Department of Medicinal Chemistry. He earned a B.S. in Chemistry from the University of Nevada, Reno in 1990 and a Ph.D. in chemistry from the University of California, Los Angeles in 1994. He was a Damon Runyon-Walter Winchell Cancer Research Foundation Postdoctoral Fellow at Harvard University from 1995-1998, an American Cancer Society Research Scholar in 2003, and a Camille Dreyfus Teacher Scholar in 2003. He is an Eminent Scholar of the Kansas Bioscience Authority and a Fellow of the American Association for the Advancement of Science.
Organic Synthesis, Bioorganic / Medicinal Chemistry, and Chemical Biology
The Peterson lab at KU Med. Chem. focuses on the design, synthesis, and evaluation of biologically active small molecules. Our core science is organic chemistry, and we use modern methods of solution-phase and solid-phase synthesis to prepare modulators of biological pathways and probes of cellular biology. To investigate the activity and potency of these compounds, we employ diverse cellular and biochemical assays, with a particular emphasis on fluorescence-based techniques.